Biotechnology R&D intensity in the business sector in Switzerland is forecasted to show a consistent increase from 2024 through 2028. We are seeing the value projected to rise from 34.5 in 2024 to 35.28 in 2028. This indicates a stable upward trend, with year-on-year percentage increases ranging between 0.65% and 0.29%. The Compound Annual Growth Rate (CAGR) over this period averages around 0.56%.
Future trends to watch for include:
- Technological advancements driving greater efficiency and breakthroughs in biotechnology.
- Increased public and private investment fueling R&D activities.
- Regulatory changes that may affect funding and operational frameworks for biotechnology firms.
